2m 2m 2m 2m 2m 2m 2m
TONIX PHARM HLD (TNXP)
NASDAQ
$8.99+$0.07 (+0.84%)
Price as of Oct 02, 2026 7:57 PM EDT- $158.3MMarket Cap
- -62.87%1-Year Change
- BiotechnologyIndustry
TONIX PHARM HLD (TNXP)
$8.99+$0.07 (+0.84%)
TNXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.91 | ||
Change | -$0.32 (-3.47%) | ||
Open | $9.38 | ||
High | $9.56 | ||
Low | $8.69 | ||
Previous Close | $9.23 | ||
Volume | 803,104 | ||
30-Day Average Volume | 447,247 | ||
1-Week Change | -9.63% | ||
1-Month Change | -33.41% | ||
1-Year Change | -62.87% | ||
3-Year Change | -99.48% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 17.2M | ||
Total Assets | $254.1M | ||
Market Cap | $158.3M | ||
Enterprise Value | -$17.9M | ||
Period: QTR TTM FY | |||
Revenue | $13.5M | ||
Net Income | -$40.6M | ||
Free Cash Flow | -$42.8M | ||
EBIT | -$40.6M | ||
EBITDA | -$39.9M | ||
Net Working Capital | $172.6M | ||
EPS | -$2.44 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | -1 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 100 | ||
Last Split Date | 02/05/2025 | ||
Earnings & Revenue